These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 19553638)

  • 41. Survival trends among 1,325 patients with chronic lymphocytic leukemia seen over the past 40 years in Israel.
    Shvidel L; Braester A; Bairey O; Rahimi-Levene N; Klepfish A; Herishanu Y; Shtalrid M; Polliack A; Berrebi A;
    Am J Hematol; 2011 Dec; 86(12):985-92. PubMed ID: 21919037
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Relevance of CD49d protein expression as overall survival and progressive disease prognosticator in chronic lymphocytic leukemia.
    Gattei V; Bulian P; Del Principe MI; Zucchetto A; Maurillo L; Buccisano F; Bomben R; Dal-Bo M; Luciano F; Rossi FM; Degan M; Amadori S; Del Poeta G
    Blood; 2008 Jan; 111(2):865-73. PubMed ID: 17959854
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Chronic lymphocytic leukaemia at a county hospital in southern Sweden.
    Hjalmar V; Carlsson M; Kimby E
    Med Oncol; 1996 Jun; 13(2):95-101. PubMed ID: 9013472
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chronic lymphocytic leukaemia with 17p deletion: a retrospective analysis of prognostic factors and therapy results.
    Delgado J; Espinet B; Oliveira AC; Abrisqueta P; de la Serna J; Collado R; Loscertales J; Lopez M; Hernandez-Rivas JA; Ferra C; Ramirez A; Roncero JM; Lopez C; Aventin A; Puiggros A; Abella E; Carbonell F; Costa D; Carrio A; Gonzalez M; ;
    Br J Haematol; 2012 Apr; 157(1):67-74. PubMed ID: 22224845
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Upper aerodigestive tract cancer in patients with chronic lymphocytic leukemia: incidence, stage, and outcome.
    Pagedar NA; Halfdanarson TR; Karnell LH; Hoffman HT; Funk GF
    Arch Otolaryngol Head Neck Surg; 2012 Dec; 138(12):1171-5. PubMed ID: 23247237
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Analysis of racial variations in disease characteristics, treatment patterns, and outcomes of patients with chronic lymphocytic leukemia.
    Nabhan C; Chaffee KG; Slager SL; Galanina N; Achenbach SJ; Schwager SM; Kay NE; Shanafelt TD
    Am J Hematol; 2016 Jul; 91(7):677-80. PubMed ID: 27013143
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Relationship of blood monocytes with chronic lymphocytic leukemia aggressiveness and outcomes: a multi-institutional study.
    Friedman DR; Sibley AB; Owzar K; Chaffee KG; Slager S; Kay NE; Hanson CA; Ding W; Shanafelt TD; Weinberg JB; Wilcox RA
    Am J Hematol; 2016 Jul; 91(7):687-91. PubMed ID: 27037726
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment-related mortality and graft-versus-leukemia activity after allogeneic stem cell transplantation for chronic lymphocytic leukemia using intensity-reduced conditioning.
    Dreger P; Brand R; Hansz J; Milligan D; Corradini P; Finke J; Deliliers GL; Martino R; Russell N; Van Biezen A; Michallet M; Niederwieser D;
    Leukemia; 2003 May; 17(5):841-8. PubMed ID: 12750695
    [TBL] [Abstract][Full Text] [Related]  

  • 49. HLA-identical sibling bone marrow transplantation in younger patients with chronic lymphocytic leukemia. European Group for Blood and Marrow Transplantation and the International Bone Marrow Transplant Registry.
    Michallet M; Archimbaud E; Bandini G; Rowlings PA; Deeg HJ; Gahrton G; Montserrat E; Rozman C; Gratwohl A; Gale RP
    Ann Intern Med; 1996 Feb; 124(3):311-5. PubMed ID: 8554226
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of outcome of patients with CLL who are referred or nonreferred to a specialized CLL clinic: a Canadian population-based study.
    Beiggi S; Banerji V; Deneka A; Griffith J; Gibson SB; Johnston JB
    Cancer Med; 2016 Jun; 5(6):971-9. PubMed ID: 26889755
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mapping comorbidity in chronic lymphocytic leukemia: impact of individual comorbidities on treatment, mortality, and causes of death.
    Rotbain EC; Niemann CU; Rostgaard K; da Cunha-Bang C; Hjalgrim H; Frederiksen H
    Leukemia; 2021 Sep; 35(9):2570-2580. PubMed ID: 33603143
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognostic features and survival in young adults with early/intermediate chronic lymphocytic leukemia (B-CLL): a single institution study.
    Dhodapkar M; Tefferi A; Su J; Phyliky RL
    Leukemia; 1993 Aug; 7(8):1232-5. PubMed ID: 8350623
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Single-institution long-term outcomes for patients receiving nonmyeloablative conditioning hematopoeitic cell transplantation for chronic lymphocytic leukemia and follicular lymphoma.
    Mortensen BK; Petersen SL; Kornblit B; Andersen PK; Braendstrup P; Andersen NS; Sengeløv H; Vindeløv L
    Eur J Haematol; 2012 Aug; 89(2):151-9. PubMed ID: 22574687
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prognostic features and therapeutical approaches in B-cell chronic lymphocytic leukemia: an update.
    Molica S; De Rossi G; Luciani M; Levato D
    Haematologica; 1995; 80(2):176-93. PubMed ID: 7628755
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Multicentre prospective randomised trial of fludarabine versus cyclophosphamide, doxorubicin, and prednisone (CAP) for treatment of advanced-stage chronic lymphocytic leukaemia. The French Cooperative Group on CLL.
    Johnson S; Smith AG; Löffler H; Osby E; Juliusson G; Emmerich B; Wyld PJ; Hiddemann W
    Lancet; 1996 May; 347(9013):1432-8. PubMed ID: 8676625
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Chronic lymphocytic leukemia patients with HLA-B27 referred for allogeneic hematopoietic stem cell transplantation do not have worse outcomes: Results of a population-based case series analysis in British Columbia, Canada.
    Huang SJ; Chan J; Bruyère H; Allan LL; Gerrie AS; Toze CL
    Leuk Res; 2019 Sep; 84():106193. PubMed ID: 31325731
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Presenting features and outcome of chronic lymphocytic leukemia patients diagnosed at age 80 years or more. An ICLLSG study.
    Bairey O; Ruchlemer R; Rahimi-Levene N; Herishanu Y; Braester A; Berrebi A; Polliack A; Klepfish A; Shvidel L;
    Ann Hematol; 2011 Oct; 90(10):1123-9. PubMed ID: 21614458
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Treatment of older patients with chronic lymphocytic leukemia: key questions and current answers.
    Shanafelt T
    Hematology Am Soc Hematol Educ Program; 2013; 2013():158-67. PubMed ID: 24319177
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical progression and outcome of patients with monoclonal B-cell lymphocytosis.
    Fung SS; Hillier KL; Leger CS; Sandhu I; Vickars LM; Galbraith PF; Li CH; Leitch HA
    Leuk Lymphoma; 2007 Jun; 48(6):1087-91. PubMed ID: 17577771
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Chronic lymphocytic leukemia: a changing natural history?
    Rozman C; Bosch F; Montserrat E
    Leukemia; 1997 Jun; 11(6):775-8. PubMed ID: 9177426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.